Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neovasc Inc (NVCN)

Neovasc Inc (NVCN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,783
  • Shares Outstanding, K 2,707
  • Annual Sales, $ 2,550 K
  • Annual Income, $ -24,890 K
  • 60-Month Beta 2.48
  • Price/Sales 5.35
  • Price/Cash Flow N/A
  • Price/Book 0.26
Trade NVCN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -1.25
  • Number of Estimates 1
  • High Estimate -1.25
  • Low Estimate -1.25
  • Prior Year -2.25
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.64 +17.78%
on 05/12/22
10.25 -46.73%
on 04/20/22
-4.11 (-42.92%)
since 04/13/22
3-Month
4.64 +17.78%
on 05/12/22
12.75 -57.18%
on 03/04/22
-5.86 (-51.76%)
since 02/11/22
52-Week
4.64 +17.78%
on 05/12/22
28.25 -80.67%
on 06/10/21
-13.03 (-70.47%)
since 05/13/21

Most Recent Stories

More News
Neovasc (NVCN) Reports Q1 Loss, Misses Revenue Estimates

Neovasc (NVCN) delivered earnings and revenue surprises of -140.80% and 23.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

NVCN : 5.46 (+8.55%)
BSGM : 1.2200 (+20.79%)
Aspira (AWH) Reports Q1 Loss, Misses Revenue Estimates

Aspira (AWH) delivered earnings and revenue surprises of 0% and 5.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AWH : 0.4511 (+8.23%)
NVCN : 5.46 (+8.55%)
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 8.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

MASS : 16.51 (+16.02%)
NVCN : 5.46 (+8.55%)
LENSAR, Inc. (LNSR) Reports Q1 Loss, Tops Revenue Estimates

LENSAR, Inc. (LNSR) delivered earnings and revenue surprises of 23.86% and 4.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LNSR : 7.04 (+2.92%)
NVCN : 5.46 (+8.55%)
Neovasc to Report First Quarter Financial Results on May 12, 2022

VANCOUVER and MINNEAPOLIS, MN, April 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ ,  TSX : NVCN), will report financial results...

NVCN : 5.46 (+8.55%)
NVCN.TO : 7.02 (+10.20%)
Integer (ITGR) Lags Q1 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of -12.36% and 1.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ITGR : 71.97 (+1.42%)
NVCN : 5.46 (+8.55%)
Neovasc Comments on European Heart Journal Publication

Report demonstrates objective improvements in patients suffering from microvascular dysfunction VANCOUVER and MINNEAPOLIS, April 28, 2022 (GLOBE...

NVCN : 5.46 (+8.55%)
NVCN.TO : 7.02 (+10.20%)
Hologic (HOLX) Q2 Earnings and Revenues Surpass Estimates

Hologic (HOLX) delivered earnings and revenue surprises of 33.55% and 12.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

HOLX : 76.28 (+2.71%)
NVCN : 5.46 (+8.55%)
Neovasc to Participate in Bloom Burton & Co. Healthcare Investment Conference

VANCOUVER and MINNEAPOLIS, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today...

NVCN : 5.46 (+8.55%)
NVCN.TO : 7.02 (+10.20%)
Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders

VANCOUVER, April 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce...

NVCN : 5.46 (+8.55%)
NVCN.TO : 7.02 (+10.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM)...

See More

Key Turning Points

3rd Resistance Point 6.23
2nd Resistance Point 5.85
1st Resistance Point 5.65
Last Price 5.46
1st Support Level 5.07
2nd Support Level 4.69
3rd Support Level 4.49

See More

52-Week High 28.25
Fibonacci 61.8% 19.23
Fibonacci 50% 16.44
Fibonacci 38.2% 13.66
Last Price 5.46
52-Week Low 4.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar